Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 known ✓ | P00918 | 1/20 | 0.40 |
| ▸ | THRB known ✓ | P10828 | 2/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.57 |
| ▸ | USP2 | O75604 | 1/20 | 0.57 |
| ▸ | ATM | Q13315 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | GRK2 | P25098 | 1/20 | 0.50 |
| ▸ | PLEC | Q15149 | 1/20 | 0.50 |
| ▸ | ENPP2 | Q13822 | 5/20 | 0.48 |
| ▸ | FUT8 | Q9BYC5 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | APP | P05067 | 1/20 | 0.40 |
| ▸ | CA3 | P07451 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29377239 | 1.00 | PTPN1 (0.57) | PTPN1USP2ATML3MBTL1MEN1 | |
| SCHEMBL185814 | 1.00 | PTPN1 (0.57) | PTPN1USP2ATML3MBTL1MEN1 | |
| SCHEMBL29534088 | 0.88 | ENPP2 (0.50) | PTPN1USP2ATML3MBTL1MEN1 | |
| SCHEMBL29350172 | 0.87 | ENPP2 (0.56) | PTPN1USP2ATML3MBTL1MEN1 | |
| SCHEMBL2121243 | 0.87 | ENPP2 (0.56) | PTPN1USP2ATML3MBTL1MEN1 | |
| SCHEMBL2121238 | 0.87 | ENPP2 (0.56) | PTPN1USP2ATML3MBTL1MEN1 | |
| SCHEMBL185815 | 0.87 | ENPP2 (0.56) | MEN1KMT2AENPP2FUT8HTT | |
| SCHEMBL1139743 | 0.87 | ENPP2 (0.56) | MEN1KMT2AENPP2FUT8HTT | |
| SCHEMBL110153 | 0.87 | ENPP2 (0.56) | MEN1KMT2AENPP2FUT8HTT | |
| SCHEMBL28343203 | 0.86 | USP2 (0.52) | PTPN1USP2ATML3MBTL1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10259946-B1 | Sealing agents, methods of making and uses thereof | James Hardie Technology Limited (IE) | 2019-04-16 | — | — | US | disclosed |
| US-7462204-B2 | Cationic diaminopyrazoles, a process for producing them and colorants containing these compounds | WELLA AG (DE) | 2008-12-09 | — | — | US | disclosed |
| US-7458992-B2 | Dye-containing pellets for dyeing keratin fibres | WELLA AG (DE) | 2008-12-02 | — | — | US | disclosed |
| US-7361198-B2 | M-diaminobenzenes, their acid adducts and the use thereof in colorants | WELLA AG (DE) | 2008-04-22 | — | — | US | disclosed |
| US-7320711-B2 | Dyestuff for keratin fibers | WELLA AG (DE) | 2008-01-22 | — | — | US | disclosed |
| US-20070199159-A1 | Dye-containing pellets and their use | PROCTER & GAMBLE COMPANY, THE | 2007-08-30 | — | — | US | disclosed |
| WO-2007093954-A1 | DYE-CONTAINING PELLETS AND THEIR USE | THE PROCTER & GAMBLE COMPANY (US) | 2007-08-23 | — | — | WO | disclosed |
| EP-1820487-A1 | Dye-containing pellets and their use | Wella Aktiengesellschaft (DE) | 2007-08-22 | — | — | EP | disclosed |
| US-20070056120-A1 | Cationic diaminopyrazoles, a process for producing them and colorants containing these compounds | HFC PRESTIGE INTERNATIONAL OPERATIONS SWITZERLAND SÀRL (CH) | 2007-03-15 | — | — | US | disclosed |
| US-7125427-B2 | Coloring agent for keratin fibers | WELLA AG (DE) | 2006-10-24 | — | — | US | disclosed |
| US-20060183781-A1 | Novel thiazolylmethyl pyrazoles, method for the production thereof, and use thereof in dyes for keratin fibers | WELLA AG (DE) | 2006-08-17 | — | — | US | disclosed |
| US-20060162097-A1 | Dye-containing pellets for dyeing keratin fibres | HFC PRESTIGE INTERNATIONAL OPERATIONS SWITZERLAND SÀRL (CH) | 2006-07-27 | — | — | US | disclosed |
| US-20060121070-A1 | Dyestuff for keratin fibers | HFC PRESTIGE INTERNATIONAL HOLDING SWITZERLAND S.A.R.L (CH) | 2006-06-08 | — | — | US | disclosed |
| US-20060047172-A1 | M-diaminobenzenes, their acid adducts and the use thereof in colorants | Wella GmbH (DE) | 2006-03-02 | — | — | US | disclosed |
| US-20040098815-A1 | Coluoring agent for keratin fibres | HFC PRESTIGE INTERNATIONAL HOLDING SWITZERLAND S.A.R.L (CH) | 2004-05-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060047172-A1 | M-diaminobenzenes, their acid adducts and the use thereof in colorants | DDT, NQO1, MDH2 | CA2 2299/4885THRB 2956/4885PTPN1 3803/4885 |
| US-20060183781-A1 | Novel thiazolylmethyl pyrazoles, method for the production thereof, and use thereof in dyes for keratin fibers | KRT18, CBR3, CDC73 | CA2 2589/4885THRB 3939/4885PTPN1 4285/4885 |
| US-20040098815-A1 | Coluoring agent for keratin fibres | KRT18, DSG1, KIF5B | CA2 3481/4885THRB 4724/4885PTPN1 4197/4885 |
| US-20070056120-A1 | Cationic diaminopyrazoles, a process for producing them and colorants containing these compounds | KRT18, DSP, TUBA4A | CA2 1677/4885THRB 4818/4885PTPN1 4449/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.